150 related articles for article (PubMed ID: 3052213)
1. Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity.
Hiserodt JC; Chambers WH
Ann N Y Acad Sci; 1988; 532():395-404. PubMed ID: 3052213
[No Abstract] [Full Text] [Related]
2. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
[TBL] [Abstract][Full Text] [Related]
3. [Role of lymphokines in the generation of cytotoxic T lymphocytes].
Kasakura S
Rinsho Ketsueki; 1984 Apr; 25(4):479-87. PubMed ID: 6236311
[No Abstract] [Full Text] [Related]
4. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of alloimmune T cells on the generation of cytolytic responses of lymphokine-activated killer cells.
Sugarbaker PH; Matthews W; Steller EP; Eggermont AM
J Biol Response Mod; 1987 Aug; 6(4):430-45. PubMed ID: 3498012
[TBL] [Abstract][Full Text] [Related]
6. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
Mulé JJ; Yang J; Shu S; Rosenberg SA
J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
[TBL] [Abstract][Full Text] [Related]
7. Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells.
Hiserodt JC; Vujanovic NL; Reynolds CW; Herberman RB; Cramer DV
Prog Clin Biol Res; 1987; 244():137-46. PubMed ID: 2958869
[No Abstract] [Full Text] [Related]
8. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
[TBL] [Abstract][Full Text] [Related]
9. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
Owen-Schaub LB; Gutterman JU; Grimm EA
Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
[TBL] [Abstract][Full Text] [Related]
10. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
11. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
Mulé JJ; Krosnick JA; Rosenberg SA
J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
[TBL] [Abstract][Full Text] [Related]
12. Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice.
Andriole GL; Mulé JJ; Hansen CT; Linehan WM; Rosenberg SA
J Immunol; 1985 Nov; 135(5):2911-3. PubMed ID: 3876368
[TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.
Merluzzi VJ; Savage DM; Smith MD; Last-Barney K; Mertelsmann R; Moore MA; Welte K
J Immunol; 1985 Sep; 135(3):1702-6. PubMed ID: 3894518
[TBL] [Abstract][Full Text] [Related]
14. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
Ting CC; Hargrove ME; Yun YS
J Immunol; 1988 Aug; 141(3):741-8. PubMed ID: 3260909
[TBL] [Abstract][Full Text] [Related]
15. Induction of lymphokine activated killer cells in serum-free medium.
Froelich CJ; Guiffaut S
J Immunol Methods; 1986 Feb; 86(2):205-11. PubMed ID: 3484769
[TBL] [Abstract][Full Text] [Related]
16. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.
Phillips JH; Lanier LL
J Exp Med; 1986 Sep; 164(3):814-25. PubMed ID: 3489062
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine-activated killer cells. Induction and function.
Grimm EA; Owen-Schaub LB; Loudon WG; Yagita M
Ann N Y Acad Sci; 1988; 532():380-6. PubMed ID: 3140701
[No Abstract] [Full Text] [Related]
18. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulation of lymphokine-activated killer cells.
Nair MP; Schwartz SA
Clin Immunol Immunopathol; 1988 Oct; 49(1):28-40. PubMed ID: 3409554
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
Yang SS; Malek TR; Hargrove ME; Ting CC
J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
